Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Anticancer Research|December 31, 2024
Development of a Prognostic Model for Stage IV Colorectal Cancer Using Metastatic PatternsHidetaka Kawamura, Takahiro Imaizumi, Teppei Miyakawa, et al.Annals of Gastroenterological Surgery|May 18, 2026
Prognostic Impact of Histologic Subtypes in Mismatch Repair-Deficient/Microsatellite Instability-High Colorectal Cancer: A Single-Center Retrospective Study of 1127 Stage 0-IV PatientsTomoyuki Momma, Hirokazu Okayama, Sohei Hayashishita, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 30, 2023
[Remodeling of the Tumor Microenvironment by Radiotherapy through the cGAS-STING Pathway in Esophageal Squamous Cell Carcinoma]Shotaro Nakajima, Kosaku Mimura, Akinao Kaneta, et al.Surgical Case Reports|June 12, 2026
Laparoscopic Peritoneal Flap Closure for Internal Hernia Associated with Colostomy: Two Case ReportsRyo Kanoda, Hisahito Endo, Masanori Katagata, et al.International Journal of Molecular Sciences|May 11, 2024
TGFβ-Responsive Stromal Activation Occurs Early in Serrated Colorectal CarcinogenesisHideaki Tsumuraya, Hirokazu Okayama, Masanori Katagata, et al.Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|February 22, 2023
ARID1A deficiency is targetable by AKT inhibitors in HER2-negative gastric cancerTakahiro Sato, Motonobu Saito, Shotaro Nakajima, et al.Journal of Gastrointestinal Cancer|June 26, 2026
Prognostic Factors for Cancer-Specific Survival after Recurrence in Chemo-Naïve Stage I-III Colorectal CancerTomoyuki Momma, Hirokazu Okayama, Makoto Hasegawa, et al.Cancers|October 28, 2023
TIM-3 Expression and M2 Polarization of Macrophages in the TGFβ-Activated Tumor Microenvironment in Colorectal CancerMasanori Katagata, Hirokazu Okayama, Shotaro Nakajima, et al.Cancers|May 25, 2024
TIM-3 Expression on Dendritic Cells in Colorectal CancerMei Sakuma, Masanori Katagata, Hirokazu Okayama, et al.Cancers|November 27, 2025
KRAS G12A Identifies a High-Risk Subset in Resected Stage II-III Colorectal CancerTomoyuki Momma, Hirokazu Okayama, Sohei Hayashishita, et al.Pageof 2